Abstract
Background:
Epilepsy is a chronic disorder that typically requires lifelongpharmacologic treatment. The choice of an antiepileptic drug (AED), therefore, requires careful consideration of efficacy and tolerability. However, the majority of patients with new-onset seizures are initially treated by physicians in the emergency department (ED) or by non-ED physicians (primary care physicians or internists), with phenytoin being the most common AED prescribed for initial therapy, and the long-term adverse effects of AEDs are often overlooked.
Objective:
The aim of this survey was to examine the perspectives of neurologistsand epileptologists concerning initial therapies prescribed by ED physicians and non-ED physicians for newly diagnosed partial seizures, particularly phenytoin, and the suitability of these therapies for long-term management of the disease.
Methods:
A computerized survey was conducted during the 2004 AmericanAcademy of Neurology meeting. The survey consisted of 10 questions concerning the use of AEDs in the initial and long-term treatment of newly diagnosed partial seizures.
Results:
The responses of 268 practitioners were analyzed. Survey participants indicated that 71% of patients referred to them by ED physicians were receiving phenytoin, whereas 59% of patients referred to them by non-ED physicians were receiving phenytoin. Seventy-six percent of survey participants responded that they would switch a patient having partial seizures referred from the ED to another AED. Seventy-eight percent indicated that they did not believe that the medications being received by patients with newly diagnosed partial seizures in the ED were suitable for long-term epilepsy treatment.
Conclusion:
Although appropriate treatment might vary in the acute and chronic settings, and phenytoin is used as a primary agent for acute treatment of seizures presenting in the ED, the results of the present survey suggest a discrepancy between the medications that primary care and ED physicians prescribe for newly diagnosed partial seizures and those that specialists prescribe for long-term therapy.
Key words: antiepileptic drugs, bone, bone mineral density, phenytoin, survey, partial epilepsy, neurologist, epileptologist
Full Text
The Full Text of this article is available as a PDF (572.1 KB).
References
- 1.Meador K.J., Gilliam F.G., Kanner A.M., Pellock J.M. Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav. 2001;2:SS1–SS17. doi: 10.1006/ebeh.2001.0235. [DOI] [PubMed] [Google Scholar]
- 2.Devinsky 0., Cramer J. Safety and efficacy of standard and new antiepileptic drugs. Neurology. 2000;55(Suppl 3):S5–S10. [PubMed] [Google Scholar]
- 3.Pellock J.M., Smith M.C., Cloyd J.C. Extended-release formulations: Simplifying strategies in the management of antiepileptic drug therapy. Epilepsy Behav. 2004;5:301–307. doi: 10.1016/j.yebeh.2004.01.009. [DOI] [PubMed] [Google Scholar]
- 4.Smith M.C., Buelow J.M. Epilepsy. Dis Mon. 1996;42:729–827. doi: 10.1016/s0011-5029(96)90020-6. [DOI] [PubMed] [Google Scholar]
- 5.Pugh M.J., Cramer J., Knoefel J. Potentially inappropriate antiepileptic drugs for elderly patients with epilepsy. J Am Geriatr Soc. 2004;52:417–422. doi: 10.1111/j.1532-5415.2004.52115.x. [DOI] [PubMed] [Google Scholar]
- 6.Wilder B.J., Bruni J. Phenytoin and other hydantoins: Clinical efficacy and use in epilepsy. In: Levy R.H., Mattson R.H., Meldrum B.S., Perucca E., editors. Antiepileptic Drugs. Lippincott Williams & Wilkins; Philadelphia, Pa: 2002. pp. 591–596. [Google Scholar]
- 7.Karceski S., Morrell M., Carpenter D. The Expert Consensus Guideline Series: Treatment of Epilepsy. Epilepsy and Behav. 2001;2:A1–A50. [Google Scholar]
- 8.Camfield P., Camfield C. Acute and chronic toxicity of antiepileptic medications: A selective review. Can J Neurol Sci. 1994;21:57–511. doi: 10.1017/s0317167100040750. [DOI] [PubMed] [Google Scholar]
- 9.Bruni J. Phenytoin and other hydantoins: Adverse effects. In: Levy R.H., Mattson R.H., Meldrum B.S., Perucca E., editors. Antiepileptic Drugs. Lippincott Williams & Wilkins; Philadelphia, Pa: 2002. pp. 605–610. [Google Scholar]
- 10.Brodie M.J., Dichter M.A. Antiepileptic drugs. N Engl J Med. 1996;334:168–175. doi: 10.1056/NEJM199601183340308. [DOI] [PubMed] [Google Scholar]
- 11.French J. The long-term therapeutic management of epilepsy. Ann Intern Med. 1994;120:411–422. doi: 10.7326/0003-4819-120-5-199403010-00010. [DOI] [PubMed] [Google Scholar]
- 12.De Marcos F.A., Ghizoni E., Kobayashi E. Cerebellar volume and long-term use of phenytoin. Seizure. 2003;12:312–315. doi: 10.1016/s1059-1311(02)00267-4. [DOI] [PubMed] [Google Scholar]
- 13.Pack A.M. The association between antiepileptic drugs and bone disease. Epilepsy Curr. 2003;3:91–95. doi: 10.1046/j.1535-7597.2003.03306.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ali II., Schuh L., Barkley G.L., Gates J.R. Antiepileptic drugs and reduced bone mineral density. Epilepsy Behav. 2004;5:296–300. doi: 10.1016/j.yebeh.2004.02.005. [DOI] [PubMed] [Google Scholar]
- 15.Valmadrid C., Voorhees C., Litt B., Schneyer C.R. Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol. 2001;58:1369–1374. doi: 10.1001/archneur.58.9.1369. [DOI] [PubMed] [Google Scholar]
- 16.Pack A.M., Morrell M.J. Adverse effects of antiepileptic drugs on bone structure: Epidemiology, mechanisms and therapeutic implications. CNS Drugs. 2001;15:633–642. doi: 10.2165/00023210-200115080-00006. [DOI] [PubMed] [Google Scholar]
- 17.Pack A.M., Morrell M.J. Epilepsy and bone health in adults. Epilepsy Behav. 2004;5(Suppl 2):S24–S29. doi: 10.1016/j.yebeh.2003.11.029. [DOI] [PubMed] [Google Scholar]
- 18.Hahn T.J., Scharp C.R., Richardson C.A. Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fetal rat bone resorption in vitro. J Clin Invest. 1978;62:406–414. doi: 10.1172/JCI109142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Asconape J.J. Some common issues in the use of antiepileptic drugs. Semin Neurol. 2002;22:27–39. doi: 10.1055/s-2002-33046. [DOI] [PubMed] [Google Scholar]